Shahid Shafi, MD, Named CEO of Surgical Group of North Texas

Surgical Group of North Texas is pleased to announce the appointment of Shahid Shafi, MD, as Chief Executive Officer, effective January 1, 2017. Dr. Shafi has been a surgeon with Surgical Group of North Texas since 2009.

After receiving his medical degree at Aga Khan University in Pakistan in 1988, Dr. Shafi moved to the US. He obtained a Master’s Degree in Public Health from the Johns Hopkins University in Baltimore. He then went on to complete his General Surgery residency at New Jersey Medical School in Newark, NJ, and Trauma Surgery and Surgical Critical Care Fellowship at the University of Pennsylvania. Prior to joining Surgical Group of North Texas, he was an Assistant Professor of Surgery at the University of Texas Southwestern and Director for Trauma Surgery service line at Parkland Hospital in Dallas. He is currently pursuing an Executive MBA at SMU.

Dr. Shafi’s experience in measuring and reporting quality of surgical care has earned him national and international recognition. He has published over 100 articles in medical journals, and has served in leadership roles at local, state, and national level in the medical field. He also serves as a Medical Director for Baylor Scott & White Quality Alliance, focusing on improving quality of surgical care in their network of over 45 hospitals and over 4600 physicians across Texas.

Dr. Shafi is looking forward to his new role as the first CEO of the Surgical Group of North Texas. He plans to focus on maintaining high quality of surgical care provided by their surgeons, ensuring safe surgery, and treating patients and their families with kindness, compassion, and respect.

Dr. Sina Matin, one of the founders of Surgical Group of North Texas, stated, “Dr. Shafi’s appointment to lead our group reflects our ongoing commitment to return our patients to health through safe, timely, and effective surgery. Dr. Shafi is fully committed to advancing our goals, and we are thrilled that he will lead us through the next phase our growth.”

#     #     #

About Surgical Group of North Texas

Surgical Group of North Texas is an independent general surgery practice with eight surgeons who have provided high quality surgical care since 1991. They specialize in advanced hernia repair, bariatric surgery, breast cancer, incisionless reflux surgery, oncologic surgery, vein surgery, and minimally invasive advanced laparoscopic and robotic surgery. They practice at multiple locations, including hospitals affiliated with Baylor Scott & White Health, Texas Health Resources, HCA, Methodist, and other local hospitals.

Sina Matin, MD Appointed to Board of Texas Association of Bariatric Surgery

Dr. Sina Matin has been appointed as the northeast regional board member for the Texas Association of Bariatric Surgery. TABS was established in 2005 as a resource for physicians, bariatric surgeons, and weight loss surgery patients. Through TABS, members can share ideas, access referral networks, and participate in patient education on health and wellness. The TABS membership includes 65 physicians and surgeons across the state and is governed by a volunteer board of directors.

With his appointment to the TABS board, Dr. Matin adds to his list of medical associations and certifications. He is Board Certified by the American Board of Surgery and is a fellow of the American College of Surgeons. He is in private practice with Surgical Group on North Texas and works within the Baylor Health Care System. Dr. Matin is a General Surgeon with additional training in advanced laparoscopic surgery, robotic surgery, and bariatric surgery. He follows a consultative approach with his patients and is known for his outgoing personality and caring bedside manner.

After receiving his medical degree from the Medical College of Virginia, Dr. Matin completed his surgical residency and research fellowship at the University of Texas in Galveston (UTMB). He then trained in advanced laparoscopic surgery at Baylor College of Medicine in Houston and as faculty at UTMB.

Dr. Matin is active in and recognized by the following organizations: the Texas Medical Association, American College of Surgeons, Society of Laparoendoscopic Surgeons, Alpha Omega Alpha Medical Honor Society, American Society for Metabolic and Bariatric Surgery, and Society of American Gastrointestinal and Endoscopic Surgeons.

To make an appointment with Dr. Matin, call 817.305.5061 or contact your primary care physician for a referral.

#     #     #

About Surgical Group of North Texas

The Surgical Group of North Texas is a general surgery practice with specialists in breast cancer surgery, bariatric surgery, and oncologic surgery.  They also offer minimally invasive techniques such as advanced laparoscopic surgery and robotic surgery.  Surgical Group of North Texas is known for their experienced surgeons, quality care, and compassionate relationships with their patients.  For more information, please visit

Shahid Shafi, M.D. Presented Five Star Spirit Award

(January 31, 2012) Grapevine, TX – Dr. Shahid Shafi of Surgical Group of North Texas wins Five Star Spirit Award from Baylor Regional Medical Center at Grapevine.  The award was created because as a health care organization, Baylor’s customers and colleagues expect them to provide safe, quality, compassionate heath care.  They understand that the people of an organization are its biggest asset and this is a way to recognize their best people.

Due to Dr. Shafi’s numerous professional achievements, outstanding notoriety, and commitment to his patients and staff, he is the model recipient for this prestigious award.  In November of last year, Dr. Shafi was awarded his first Gold Star pin for providing Five Star service, a nomination submitted by an employee, patient, physician, or guest describing him as the embodiment of the Baylor Grapevine Five Star Spirit.

Dr. Shafi has been practicing General and Robotic Surgery with Surgical Group of North Texas (SGNT) for over three years. During this time, he has also been performing research for the improvement of surgical care at the Baylor Institute for Healthcare Research and Improvement.

Prior to joining SGNT, Dr. Shafi spent six years as a professor, researcher, and trauma surgeon at the University of Texas Southwestern Medical School and Parkland Memorial Hospital. He has received many honors and appointments during his notable career so far, including appointments to the North Texas Trauma Regional Advisory Council and the Texas Governor’s EMS and Trauma Advisory Council, was a founder of the American College of Surgeons Trauma Quality Program, and speaks both nationally and abroad on key surgical issues.

To make an appointment with Dr Shafi, call 817-251-0700 or contact your primary care physician for a referral. For more details on the Surgical Group of North Texas, go to

Organized Screening Leads to Breast Cancer Overdiagnosis?

Journal Watch reported on the following study done by BMJ, a British journal:

“Mammography-detected cancers represent “overdiagnosis” in about one third of cases, according to an international study published online in BMJ. (Overdiagnosis is the detection of cancers that will not ultimately cause symptoms or death.)

Researchers reviewed published trends in breast cancer incidence for 7 years before and 7 after the full implementation of publicly organized screening in the U.K., Canada, Australia, Sweden, and Norway. After adjustment for the presence of older, previously screened women, the researchers concluded that about half the cancers detected represented overdiagnosis. When carcinomas in situ were excluded, the proportion was about one third.

An American editorialist writes: “The question is no longer whether overdiagnosis occurs, but how often it occurs.” He recommends a trial “to test higher thresholds [of diagnosis], such as only recommending biopsy for breast masses larger than a certain size.””

Ed Clifford, MD, Breast Surgeon with Surgical Group of North Texas had this to say regarding the study and article. “Breast cancer is not a uniform disease–all cancers do not behave in the same way. The biology of this is not clear, and may have as much to do with the immune system of the patient as it does with the cancer. The research does seem to indicate that some cancers do not pose an immediate threat to the patient. Unfortunately this study is not accompanied by any article indicating a means of distinguishing between dangerous and non-dangerous cancers. While scientifically interesting, this article changes nothing regarding current management of biopsy proven breast cancer.”

Link for complete story from BMJ: